自然化合物和草药处方用于性结肠炎和牛皮的结构亲和驱动的重新用途
Rui Tian1, Ting Hu2, Jinyuan Chang2
1Department of Anoenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
概括
一种计算方法通过准JAK1/STAT3信号,确定了天然化合物,包括9-胺和WU MEI PILL,作为治疗牛皮和性结肠炎 (UC) 的有希望的方法.
科学领域:
- 计算机化药物发现.
- 综合医学是一个整体的医学.
- 免疫学 免疫学 免疫学
背景情况:
- 牛皮和性结肠炎 (UC) 是具有共同致病因的慢性炎症性疾病.
- 生物医学提供有效的治疗方法,但由于成本而面临可访问性挑战.
- 对替代治疗策略的需求至关重要.
研究的目的:
- 开发一种用于使用天然化合物和传统医学的药物再利用的计算框架.
- 鉴定免疫媒介疾病的新疗法,如牛皮和UC.
- 解决对传统药物的再利用发展不足的战略.
主要方法:
- 使用了一个计算框架,重点关注药物向亲和力和结构理性.
- 选了针对JAK家族和化学因受体的传统草药和处方.
- 通过体内实验验验证的结果.
主要成果:
- 确定了204种具有治疗潜力的天然化合物.
- 9 - 氧坎普托塞辛和WU MEI PILL在牛皮和UC两种疾病中都显示出显著的前景.
- 在体内研究证实了通过JAK1/STAT3抑制缓解症状和改善屏障功能.
结论:
- 介绍了一种针对传统医学的定制计算方法,用于基于传统医学的药物重新使用.
- 证明了天然化合物和传统处方作为可扩展的治疗选择的潜力.
- 为指导临床决策和现代化传统医学提供了战略.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
243
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
243
Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
277
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
277
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
532
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
532
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
208
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
208


